Why insurance denies GLP-1 coverage and the 6 steps that get you approved

If you've ever tried to get a GLP-1 prescription covered in the US, you know how frustrating the process can be. Your doctor prescribes the treatment, everything seems fine, and then you call your insurance company, and that's when things get complicated. A bill for over thirteen hundred dollars a month. A prior authorization you'd never even heard of. And finally, a denial, with a vague explanation about medical necessity.

This story isn't a one-off. It's the experience of millions of Americans trying to access GLP-1 medications for weight loss. And the reason it keeps repeating is that the system isn't really evaluating whether you need the medication. It's evaluating whether your paperwork proves you need it. Those are two very different tests, and once you understand the difference, your odds change.

Why this is so complicated in the first place

GLP-1s are medications that mimic a natural hormone called GLP-1, which regulates blood sugar, slows down digestion, and reduces appetite. For a lot of patients, the result is weight loss of up to twenty percent of their body weight. Those are results the previous generation of weight-loss drugs never came close to, which is exactly why demand exploded, and exactly why insurers built walls around them.

The names everyone knows in 2026:

The problem is that these treatments are expensive to produce, running anywhere from nine hundred to fifteen hundred dollars a month depending on the dose. And insurance companies want to keep costs down as much as possible. That tension, a genuinely effective drug with a genuinely high price and enormous demand, is the whole story behind every denial letter.

How US health insurance actually decides

To understand why getting coverage is so hard, you need to understand the machinery. Every insurance plan has a document called a Summary of Benefits and Coverage, which explains what's covered and what isn't. It's the contract, and almost nobody reads it until they're already in trouble.

Medications are organized into what's called a formulary, split into tiers. Cheap generics sit in tier one, preferred brands in tier two, and specialty drugs like GLP-1s almost always end up in the most expensive tiers, with more paperwork and more restrictions attached.

And behind the scenes, there are companies called pharmacy benefit managers (PBMs), who negotiate prices and set the rules on behalf of insurance companies. They're the invisible layer most patients never hear about, and they're often the ones who actually decide what your plan requires.

That's why two people who seemingly have the same insurance can end up in completely different situations.

Same insurer name on the card, same medication, same BMI, but a different employer contract, different PBM, different formulary, different answer. If a friend told you their plan covered Zepbound instantly, that tells you almost nothing about yours.

The 5 reasons GLP-1 claims get denied

Denials feel arbitrary from the outside. They aren't. Nearly all of them trace back to one of five specific failures, and notice how many are about documentation rather than your actual health:

1. Medical necessity isn't established

The insurer wants clinical evidence, not just a prescription. A doctor's signature alone doesn't meet their internal standard of proof: they're looking for a documented clinical picture that justifies the cost.

2. Prior authorization was never done

That administrative step many patients only find out about at the pharmacy counter, when the claim has already bounced. It isn't optional on specialty-tier drugs, and it has to happen before the prescription is filled, not after.

3. BMI below the threshold

The standard bar is a BMI of 30, or 27 with at least one weight-related condition such as hypertension or type 2 diabetes. If your chart doesn't state the qualifying number, the reviewer treats it as not met.

4. Comorbidities aren't documented

Not that you don't have them, but that they're missing from the medical record the reviewer is reading. Sleep apnea you've mentioned in conversation but that never made it into the chart doesn't count. Undocumented equals nonexistent.

5. Step therapy requirements

You have to prove you've already tried cheaper treatments before you can get access to a GLP-1. No proof, no approval, and "we discussed it" isn't proof. The attempts need dates and records.

Look at that list again and you'll notice something useful: four of these five are records problems, not medical problems. That's good news, because records can be fixed before you submit, which is exactly what the next section is about.

The 6-step playbook to get approved

Here's the sequence that turns a likely denial into a defensible claim. Do these in order, because skipping ahead is how people end up appealing something they could have gotten right the first time.

Step 1: review your insurance plan in detail

Open the Summary of Benefits and Coverage and look for three things specifically: exclusions, the medication's tier, and prior authorization requirements. Some plans exclude weight-loss drugs outright, and it's better to know that on day one than after three weeks of paperwork.

Step 2: confirm medical eligibility with your doctor

Make sure your BMI, comorbidities, and lab results are properly documented in the chart. This is the step where "I know I have sleep apnea" needs to become a line in your record. It's also the cheapest step to get right, and the one most people skip.

Step 3: work closely with your doctor on the case

Your physician needs to build a strong case, including a letter of medical necessity. This letter does more work than anything else in the file: it's the document that answers denial reason #1 directly, in the language the reviewer is trained to look for.

Step 4: submit a complete prior authorization

Every possible supporting document, attached the first time, so there's no room for a quick denial. An incomplete PA is the easiest thing in the world for a reviewer to reject, and resubmitting costs you weeks.

Step 5: if denied, get the reason in writing

Request the denial letter with the exact reason stated. A phone call telling you "it wasn't medically necessary" is not something you can appeal against. A written reason is, because it tells you precisely what to rebut.

Step 6: appeal the specific reason

Address that stated reason with targeted evidence and clinical literature. Don't re-send the original file. Answer the objection they actually raised, point by point. This is where a large share of initial denials get overturned.

Ask for the right drug: Wegovy, not Ozempic

One important thing to remember is that Wegovy and Zepbound are FDA-approved specifically for weight management, even without diabetes. Ozempic, on the other hand, is only approved for diabetes, so using it for weight loss is considered off-label, and rarely covered.

This trips up an enormous number of claims. Same molecule, same manufacturer, different label, completely different coverage outcome. If your doctor wants to prescribe semaglutide for weight loss, ask about Wegovy instead.

Insurer by insurer: what to expect

Every company has its own rules, and knowing yours in advance saves weeks:

The Medicare GLP-1 Bridge: $50/month

For Medicare, there's a real shift happening in 2026. A new program called the Medicare GLP-1 Bridge launched in July 2026, letting eligible beneficiaries access medications like Wegovy or Zepbound for just fifty dollars a month, regardless of income.

To qualify, you need to be at least eighteen years old and meet certain criteria:

• A BMI of 35 or higher, or
• A BMI of 30 with heart failure or hard-to-control hypertension.

If you're on Medicare and were told a year ago that GLP-1s simply weren't covered, that information is now out of date. It's worth re-checking.

Even with coverage, there are ways to cut costs

Approval isn't the finish line: what you actually pay each month still varies enormously.

Manufacturer savings cards can bring your copay down to zero to twenty-five dollars a month for a year or two, but they don't work with Medicare or Medicaid. There are also copay assistance programs, and for uninsured patients, patient assistance programs offered directly by manufacturers.

And if coverage simply isn't happening on your plan, that's not the end of the road either. Our guide to getting GLP-1s without insurance covers the routes that don't depend on an insurer saying yes, and our cheapest programs tracker compares what people are actually paying right now.

So what should you actually do?

The denial you received probably wasn't a judgment about whether you need treatment. It was a judgment about whether the file in front of the reviewer proved it, under rules written by a PBM you've never heard of, against a formulary tier designed to slow you down.

That's a fixable problem. Document the BMI and comorbidities, ask for the on-label drug, submit a complete prior authorization with a letter of medical necessity, and if it still comes back negative, get the reason in writing and appeal that reason specifically. Meanwhile, if you'd rather not wait months for a decision, a vetted telehealth platform can get you into treatment at a predictable monthly price starting today.

Medical disclaimer: this guide covers insurance processes and costs, not medical advice. Coverage rules vary by plan, employer contract and region, and change over time, so always verify with your own insurer. GLP-1 therapy is prescription treatment; always consult a licensed healthcare provider.